Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer”
Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00017407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies
ClinicalTrials.gov study NCT02504346. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
ClinicalTrials.gov study NCT02788461. IPD Sharing: NO. Countries: 1. Publications: 1.
Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03110978. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT05441956. IPD Sharing: NO. Countries: 1. Publications: 1.
10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00004238. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00005055. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03958097. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy
ClinicalTrials.gov study NCT05468242. IPD Sharing: NO. Countries: 1. Publications: 7.
Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00880971. IPD Sharing: Not stated. Countries: 1. Publications: 13.
Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib
ClinicalTrials.gov study NCT03727477. IPD Sharing: NO. Countries: 1. Publications: 2.
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).
ClinicalTrials.gov study NCT03562819. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00583830. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer
ClinicalTrials.gov study NCT02410369. IPD Sharing: NO. Countries: 1. Publications: 9.
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT03127449. IPD Sharing: NO. Countries: 1. Publications: 1.
Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06406608. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05652868. IPD Sharing: YES. Countries: 7. Publications: 1.
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00006229. IPD Sharing: NO. Countries: 14. Publications: 3.
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05577702. IPD Sharing: YES. Countries: 1. Publications: 0.
Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation
ClinicalTrials.gov study NCT00874419. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.